More Taxotere Cases Filed: Permanent Hair Loss Caused by Cancer Drug

Recently, lawsuits have been taken against the chemotherapy drug Taxotere, basically known as docetaxel. The company is being sued by cancer survivors for permanent hair loss.

While the maker has now updated the listed, known side effects, for all too many toughies, the update came too late. To hire best taxotere hair loss lawyers for your case you can look online.

What makes these cases so convincing is that Sanofi-Aventis was aware of the danger of permanent hair loss, yet did not warn potential users of this danger.

While it is common knowledge that cancer patients undergoing chemotherapy will lose their hair, the anticipation is that the hair loss is provisional.

Taxotere users had that anticipation because they were never warned about this consequence until the FDA forced a change to the label.

Taxotere consequences Are Widespread

According to Business Wire, over 30 lawsuits against Sanofi-Aventis have been filed claiming a failure to warn users about the risk of permanent hair loss. While 30 lawsuits may sound like a lot, it is not.

Consider this: according to the American Cancer Society, over 1.5 million new cancer cases are informed per year. Furthermore, the ACS reports that there will be almost 250,000 reported cases of breast cancer alone this year.

Taxotere is very usually used in breast cancer patients necessitating chemotherapy, and a 2012 study showed a nearly 50 percent incidence of permanent hair loss associated with docetaxel.

Can I Join a Class Action Lawsuit for Taxotere?

Presently, there is no class action lawsuit to join, though many attorneys across the country are bringing these cases. Also, there is a current procedure pending to consolidate all the current cases so that the court can hear and choose the technical evidence one time.

The current sign is pending before a federal panel of judges on the Multi-District Litigation (MDL) panel, which will choose if hearing the presently filed cases together is pragmatic.

If the panel approves the MDL motion, it is likely that a class action will follow, however, if you think you have a claim, do not wait. Like any injury action, there are strict deadlines you must adhere to.